other material
confidence high
sentiment neutral
materiality 0.50
Dermata Therapeutics ups ATM offering by $505K to $1.66M total
Dermata Therapeutics, Inc.
- Increased maximum aggregate offering price under ATM agreement with H.C. Wainwright by $505,000 to $1,662,761.
- Previously sold $1,157,247.99 of common stock under the June 7, 2024 Sales Agreement.
- Additional $505,000 of shares authorized under the current prospectus supplement.
- Legal opinion on share legality filed as Exhibit 5.1.